UA83094C2 - Tablet of citalopram hydrobromide - Google Patents
Tablet of citalopram hydrobromideInfo
- Publication number
- UA83094C2 UA83094C2 UAA200607053A UAA200607053A UA83094C2 UA 83094 C2 UA83094 C2 UA 83094C2 UA A200607053 A UAA200607053 A UA A200607053A UA A200607053 A UAA200607053 A UA A200607053A UA 83094 C2 UA83094 C2 UA 83094C2
- Authority
- UA
- Ukraine
- Prior art keywords
- tablet
- citalopram hydrobromide
- tablets
- preparation
- particle size
- Prior art date
Links
- WIHMBLDNRMIGDW-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;hydron;bromide Chemical compound [Br-].O1CC2=CC(C#N)=CC=C2C1(CCC[NH+](C)C)C1=CC=C(F)C=C1 WIHMBLDNRMIGDW-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000584 citalopram hydrobromide Drugs 0.000 title abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000003826 tablet Substances 0.000 abstract 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000007941 film coated tablet Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0303790A HU227491B1 (en) | 2003-11-25 | 2003-11-25 | Tablet containing citalopram hydrogen bromide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA83094C2 true UA83094C2 (en) | 2008-06-10 |
Family
ID=89981808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200607053A UA83094C2 (en) | 2003-11-25 | 2004-11-24 | Tablet of citalopram hydrobromide |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1694321A1 (ru) |
| BG (1) | BG109587A (ru) |
| CZ (1) | CZ2006376A3 (ru) |
| EA (1) | EA010290B1 (ru) |
| HU (1) | HU227491B1 (ru) |
| PL (1) | PL379864A1 (ru) |
| SK (1) | SK50532006A3 (ru) |
| UA (1) | UA83094C2 (ru) |
| WO (1) | WO2005051374A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI358407B (en) * | 2005-06-22 | 2012-02-21 | Lundbeck & Co As H | Crystalline base of escitalopram and orodispersibl |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6607751B1 (en) * | 1997-10-10 | 2003-08-19 | Intellipharamaceutics Corp. | Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum |
| IS6021A (is) * | 2000-08-10 | 2001-10-20 | H. Lundbeck A/S | Lyfjasamsetningar sem innihalda sítalópram |
| AU2001100195B4 (en) * | 2001-01-05 | 2001-12-20 | H Lundbeck As | Pharmaceutical composition containing citalopram. |
-
2003
- 2003-11-25 HU HU0303790A patent/HU227491B1/hu unknown
-
2004
- 2004-11-24 SK SK5053-2006A patent/SK50532006A3/sk not_active Application Discontinuation
- 2004-11-24 PL PL379864A patent/PL379864A1/pl not_active Application Discontinuation
- 2004-11-24 UA UAA200607053A patent/UA83094C2/ru unknown
- 2004-11-24 EP EP04798748A patent/EP1694321A1/en not_active Withdrawn
- 2004-11-24 WO PCT/HU2004/000110 patent/WO2005051374A1/en active Application Filing
- 2004-11-24 CZ CZ20060376A patent/CZ2006376A3/cs unknown
- 2004-11-24 EA EA200600932A patent/EA010290B1/ru not_active IP Right Cessation
-
2006
- 2006-06-23 BG BG109587A patent/BG109587A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200600932A1 (ru) | 2006-10-27 |
| CZ2006376A3 (cs) | 2006-10-11 |
| BG109587A (bg) | 2006-12-29 |
| HU0303790D0 (en) | 2004-03-01 |
| HU227491B1 (en) | 2011-07-28 |
| HUP0303790A2 (hu) | 2005-08-29 |
| EA010290B1 (ru) | 2008-08-29 |
| SK50532006A3 (sk) | 2006-09-07 |
| PL379864A1 (pl) | 2006-11-27 |
| WO2005051374A1 (en) | 2005-06-09 |
| EP1694321A1 (en) | 2006-08-30 |
| HUP0303790A3 (en) | 2005-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1073263A1 (en) | A process for the preparation of tablets from pharmaceutically active substances having unfavourabletabletting properties with a granulating liquid c omprising microcrystalline cellulose | |
| AU2003274681A1 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
| CA2322315A1 (en) | Fast disintegrating tablets | |
| MY125766A (en) | Flash-melt oral dosage formulation | |
| CA2433585A1 (en) | Pharmaceutical compositions containing donepezil hydrochloride | |
| AU3846901A (en) | Oral, nasal and pulmonary dosage formualtions of copolymer 1 | |
| CA2489407A1 (en) | Lasofoxifene tablet and its coating | |
| TWI264311B (en) | Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency | |
| BG104397A (en) | Extended release formulation | |
| MXPA03008420A (es) | Forma farmaceutica solida oralmente dispersa. | |
| EA201001108A1 (ru) | Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения | |
| WO2003059329A3 (en) | Polytartrate composition | |
| MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
| WO2005115346A3 (en) | Pharmaceutical composition containing risperidone | |
| NO20054417L (no) | Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter | |
| TW201129386A (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
| WO2004000265A3 (en) | Process for the preparation of robust formulations of valacyclovir hydrochloride tablets | |
| UA89349C2 (ru) | Таблетка без покрытия, которая содержит оланзапин, и способ ее получения | |
| UA83094C2 (en) | Tablet of citalopram hydrobromide | |
| UA97355C2 (ru) | Фармацевтическая композиция, включающая монтелукаст | |
| BG108686A (en) | Cytisine-containing medicamentous form | |
| LT2004062A (en) | Amlodipine bezylate tablets with improved stability | |
| BRPI0211439B8 (ru) | ||
| CA2473718A1 (en) | Immediate-release pharmaceutical dosage form comprising polymorphous tibolone | |
| AU4137300A (en) | Stable solid pharmaceutical compositions containing enalapril maleate |